Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Cell preparation for treating inflammatory enteritis

A cell preparation and cell technology, applied in cell culture active agents, animal cells, vertebrate cells, etc., can solve the problems of adverse reactions of patients, postoperative recurrence, and limited efficacy in critical cases.

Inactive Publication Date: 2019-09-06
TSINGHUA UNIV
View PDF4 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Long-term use of the above drugs will bring many adverse reactions to patients, and the curative effect on critical cases is limited
Surgical treatment is required for critically ill patients. After surgical treatment, there are also problems that seriously affect the quality of life of patients and postoperative recurrence.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cell preparation for treating inflammatory enteritis
  • Cell preparation for treating inflammatory enteritis
  • Cell preparation for treating inflammatory enteritis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0111] Example 1 Obtaining Umbilical Cord Wharton Section Mesenchymal Stem Cells

[0112] 1. Fetal umbilical cord acquisition

[0113] The umbilical cords of full-term newborns without congenital diseases were taken; the mothers had no infectious diseases such as hepatitis, syphilis, and AIDS, and the mothers and their families gave informed consent to the use of umbilical cords in the experimental research.

[0114] 2. Obtaining mesenchymal cells from the Wharton section of the umbilical cord

[0115] In a sterile laboratory bench, the umbilical cord was repeatedly washed with phosphate buffered saline (PBS) to remove residual blood. Cut the umbilical cord into small sections of 2-3cm with sterile surgical instruments, cut the umbilical cord longitudinally, remove the umbilical artery, umbilical vein and amniotic membrane, and cut the Wharton area into 0.5-1mm 3 Little pieces left and right. Obtain primary umbilical cord mesenchymal cells by tissue block culture method: sp...

Embodiment 2

[0116] Example 2 Obtaining Umbilical Cord Wharton Section Mesenchymal Stem Cell Preparation

[0117] The above-mentioned low-serum medium was used to culture Example 1 to obtain umbilical cord Wharton interval mesenchymal stem cells. Specifically, the human umbilical cord mesenchymal stem cells isolated by the tissue block method were cultured in the above-mentioned low serum medium, and when the cells were about 80% confluent, they were digested with 0.25% trypsin for 1-2 minutes, and most of the cells were used for expansion. In culture, a small fraction of cells is used to identify markers of stem cells. The expression of CD29, CD44, CD90, CD105, CD31, CD45, CD34 and HLA-DR was detected by flow cytometry (after the cells were incubated with the above corresponding antibodies, the excess antibodies were washed away, the cells were resuspended in PBS, and the The LSRFortessa instrument of BD Company detects the positive rate of each index above), and the results are as follo...

Embodiment 3

[0118] Embodiment 3 utilizes the preparation of embodiment 2 to treat the inflammatory bowel disease induced by mouse DSS

[0119] C57BL / 6 mice were adapted to the environment for 3 days, and were randomly divided into three groups, namely, the normal control group, the DSS model group (DSS is dextran sulfate sodium, which is a modeling reagent for enteritis model, purchased from MP Company) and the cell therapy group . The mice were given 3.5% DSS water for 6 days, and the cell therapy group injected 1x10 6 Individual Wharton area umbilical cord mesenchymal stem cell preparation (also known as MSCs), the injection volume is 100 microliters per mouse. In the DSS model group, PBS buffer solution with a volume of 100 microliters per rat was injected through the tail vein on the 1st, 3rd and 5th days of DSS water administration. The mice were weighed every day, and the degree of blood in stool and loose stool was detected. At the end of the experiment, the mice were sacrificed...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a cell preparation for treating inflammatory enteritis. The cell preparation is a mesenchymal stem cell preparation of Wharton's jelly of human umbilical cord; the cell preparation is derived from mesenchymal stem cells from Wharton's jelly of fetal umbilical cord; and the positive rates of CD29, CD44, CD90 and CD105 of the cell preparation detected and identified througha flow cytometry are all more than 90%, and preferably, more than 95%.

Description

technical field [0001] The invention relates to a cell preparation for treating inflammatory enteritis, which is a preparation of umbilical cord Wharton mesenchymal stem cells, its preparation method, preparation medium and application. Background technique [0002] Inflammatory bowel disease (Inflammatory Bowel Disease, IBD) is a chronic intestinal inflammatory disease, including ulcerative colitis (Ulcerative Colitis, UC) and Crohn's disease (Crohn Disease, CD), the disease is related to autoimmune function IBD is closely related to IBD disorder, which is very common in western countries. In recent years, the number of IBD cases in my country has increased sharply, and it has become a common disease of the digestive system and the main cause of chronic diarrhea. So far, its etiology and specific pathogenesis are still unclear, and there is no fundamental treatment plan for the disease clinically. The World Health Organization lists the disease as one of the modern refracto...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N5/0775A61P1/00A61P1/04
CPCA61K35/28C12N5/0668C12N2500/38C12N2501/105C12N2501/11C12N2501/115C12N2501/135C12N2501/39C12N2501/91C12N2501/998
Inventor 常智杰付艳霞盛剑秋王银银任芳丽冯亚瑞韩斌
Owner TSINGHUA UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com